[Hypocholestermic agents in therapy].
作者信息
Grossi F, Palleschi M
出版信息
Clin Ter. 1966 Oct 15;39(1):65-77.
PMID:5998858
Abstract
摘要
相似文献
1
[Hypocholestermic agents in therapy].
Clin Ter. 1966 Oct 15;39(1):65-77.
2
[Therapy of atherosclerosis: lipid regulation and direct anti-atherosclerotic effect].
Internist (Berl). 1998 Oct;39(10 Suppl Lipidregul):1-4.
3
[Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
Boll Soc Ital Cardiol. 1970;15(6):539-43.
4
[What is new? Therapy with lipid lowering agents].
Internist (Berl). 1997 Nov;38(11 Suppl Therapie):1-8.
5
[Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
Boll Soc Ital Biol Sper. 1974 Sep 15;50(17):1416-22.
6
Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?
Am J Manag Care. 2003 Aug;Suppl:1, 4-5.
7
[Atherosclerosis and Regelan].
Praxis. 1966 Aug 4;55(31):875-80.
8
[The drug therapy of hypercholesterolemia].
Dtsch Med Wochenschr. 1996 May 31;121(22):729-34. doi: 10.1055/s-2008-1043062.
9
[Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
Minerva Cardioangiol. 1998 Sep;46(9):317-8.
10
[Arteriosclerosis: how plaque heals].
MMW Fortschr Med. 2002 Dec 17;144(51-52):9.
Zotero 插件